ACN Newswire
Read More

The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

indie
6 minutes

SYDNEY, AU, Feb 15, 2023 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar covering the evolving landscape in vaccine development.Register here https://webinars.endpts.com/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/ Between 2017 and 2021, there were close to 1,400 industry-sponsored single country vaccine based clinical trials globally, with the Asia Pacific involved in over 45% of the trials. Download our latest data report here: Vaccines - Asia Pacific Clinical Trial Landscape. https://novotech-cro.com/whitepapers/vaccines-asia-pacific-clinical-trial-landscapeThe webinar, Keeping pace with the evolving global landscape in vaccine development, will hear from a panel of life science experts on the latest advancements and innovative modalities paving the way in the global vaccine development space including:- The COVID-19 impact on drug development and the regulatory landscape. - Key factors contributing to Asia Pacific being recognised as the hub for vaccine development and opportunities for biotech's to leverage. - Key consideratio...

JCN Newswire
Read More

Honda to Make Organizational Changes (Effective April 1, 2023) to Further Accelerate Electrification Business and Realize New Value Creation

ruth
2 minutes

TOKYO, Jan 24, 2023 - (JCN Newswire via SEAPRWire.com) - Honda Motor Co., Ltd. today announced that the company will make organizational and operational changes, effective April 1, 2023, as it continues working toward the fulfillment of its vision to serve people worldwide with the "joy of expanding their life's potential" in the areas of mobility and people's daily lives.With this year's changes, Honda will further solidify the direction of the organizational changes made last year with an eye toward the realization of carbon neutrality by 2050. Specifically, Honda will strive to further accelerate its electrification business and create new value by leveraging its broad and expanding range of mobility products and services.Key points of the organizational changes1) Creation of Electrification Business Development Operations2) Reorganization of Regional Operations3) Reorganization of Corporate FunctionsDetails of the organizational changes1) Creation of Electrification Business Development OperationsBased on the Business Development Operations established April last year to strengthen electrification business, the Electrification Business Development Operations will be newly creat...

ACN Newswire
Read More

SinoHytec Successfully Listed on the Main Board of HKEX

indie
3 minutes

HONG KONG, Jan 12, 2023 - (ACN Newswire via SEAPRWire.com) - The leading provider of fuel cell systems in China - Beijing SinoHytec Co., Ltd. ("SinoHytec" or the "Company", Stock Code: 2402), has successfully listed and commenced dealings on the Main Board of the Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange" or "HKEX") today, under the stock code of 2402 and the Offer Price is HK$60 per Share in board lots of 50 shares each.SinoHytec is listed on the main board of HKEX, with 17,628,000 shares being offered globally, Among them, the International Offering was moderately over-subscribed, representing approximately 1.84 times the total number of 15,865,200 Offer Shares initially available under the International Offering.The Hong Kong Public Offering was slightly over-subscribed, representing approximately 0.29 times the total number of 1,762,800 Offer Shares initially available for subscription under the Hong Kong Public Offering.The net proceeds from the Global Offering to be received by the Company is estimated to be approximately HK$982.8million, after deduction of the underwriting commissions, fees and other estimated expenses payable in connection with the Glob...

JCN Newswire
Read More

Research commenced with Keio University to discover drugs using “Chemicals Informatics”

ruth
4 minutes

TOKYO, Jan 12, 2023 - (JCN Newswire via SEAPRWire.com) - Hitachi High-Tech Solutions Corporation, in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commencing joint research that uses Materials Informatics (MI) (the Research) to improve the efficiency of the development of small molecule drugs(1).Hitachi High-Tech Solutions will be using the "Chemicals Informatics (CI)" MI tool not only by developing materials in the traditional chemical materials field but also in the field of drug discovery, to improve quality of care and QoL (Quality of Life) for people.Background to the ResearchSmall molecule drugs are mainstream drugs in the modern world, and in recent years, expectations for their use have increased, with the development of drugs such as molecular-targeted drugs that inhibit the action of proteins, which cause cancer(2). Traditionally, the process used to develop small molecule drugs has involved researchers using their knowledge and experience to select several potential compounds from an extensive library of existing compounds and then repeating experiments to adjust the structure of a compound and clarify the mechanism by w...

ACN Newswire
Read More

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

indie
3 minutes

SINGAPORE, Jan 12, 2023 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group.CBR was founded in 2002 as a consultancy company focused on assisting biotechnology and pharma companies navigate FDA requirements from early-stage development through to approval. CBR adds a group of experts to Novotech to provide US and global regulatory, scientific, quality, and clinical development services. CBR's specific regulatory expertise and services include long-range Regulatory Strategy and Writing, FDA Representation, eSubmissions, and Scientific Affairs to support requirements for cGMP commercial product development.The acquisition will further strengthen Novotech's capabilities in regulatory strategy and US FDA interactions and submissions including IND, IDE, NDA, BLA, Fast-Track, Break-through, and Orphan Drug Applications.Novotech CEO Dr. John Moller said: "CBR will provide decades of FDA regulatory experience for our biotech clients. They have experience across all product types and are highly regarded for ...

ACN Newswire
Read More

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

indie
3 minutes

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 - (ACN Newswire via SEAPRWire.com) - HighTide Therapeutics Inc. ("HighTide"), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the closing of a $107 million Series C/C+ financing led by the TCM Healthcare Fund of Guangdong, managed by China Development Bank Capital. Other investors included Yuexiu Fund and Yuthai Fund. Proceeds of the financing will be used to advance multiple global development programs, including mid-to-late-stage clinical trials, and the commercialization and business development of the company's robust pipeline. HighTide's lead candidate HTD1801, is a novel multifunctional molecule, being developed for the treatment of patients suffering from complex metabolic and digestive diseases. HighTide has successfully completed multiple clinical trials of HTD1801 and continues to advance its global development programs as follows:-- A Phase 2 clinical study in type 2 diabetes (T2DM) is near completion;-- A Phase 2b clinical study in nonalcoholic steatohepatitis (NASH) has been initiated; and -- A successful End-of-...

ACN Newswire
Read More

The best of the best real estate developers, projects prevail at 17th PropertyGuru Asia Property Awards Grand Final

indie
20 minutes

BANGKOK, THAILAND, Dec 10, 2022 - (ACN Newswire via SEAPRWire.com) - PropertyGuru Group (NYSE: PGRU), Southeast Asia's leading property technology company, today announced the regional winners representing the Best in Asia at the 17th Annual PropertyGuru Asia Property Awards Grand Final, presented by Kohler and supported by Leading Real Estate Companies of the World.-- New World Development Company Limited is hailed Best Developer (Asia) in one of two regional wins for companies from China (Hong Kong and Macau)-- Companies from Thailand and the Philippines each garner seven regional wins -- Candra Ciputra, CEO of Ciputra Group and president director of PT Ciputra Development Tbk, receives the PropertyGuru Icon awardAlso known as the finale of the 2022 PropertyGuru Asia Property Awards series, the Grand Final was presented in 48 categories at The Athenee Hotel, a Luxury Collection Hotel, Bangkok. New World Development Company Limited garnered the award of Best Developer (Asia), representing China (Hong Kong and Macau). Along with the design practice Lead8, the company also received the Best Mega Mixed Use Development (Asia) award for 11 SKIES.Representing Mainland China, Lead8 addit...

JCN Newswire
Read More

Japan, United Kingdom and Italy Formally Announce Joint Development of a Next-Generation Fighter

ruth
2 minutes

TOKYO, Dec 9, 2022 - (JCN Newswire via SEAPRWire.com) - The Government of Japan today announced the joint development of the country's next-generation fighter together with partners in the U.K. and Italy.In recent years, Mitsubishi Heavy Industries, Ltd. (MHI) has developed cutting-edge technologies for fighter through diverse research initiatives, including the "X-2," an advanced technology demonstrator jet. Since October 2020, when a contract was concluded with the Ministry of Defense on development of the future fighter aircraft (F-X), MHI has conducted a conceptual design and other development-related work. Simultaneously, MHI has been looking into the feasibility of collaboration with the U.K. and Italian defense industries under the leadership of the governments of the three nations.Following the formal announcement of the joint development by the three nations' governments, the development program will now go forward concurrently in Japan, the U.K. and Italy. MHI will work closely with the government authorities and corporate partners from all three nations, in order to develop the next-generation fighter, pooling our respective cutting-edge technologies and expertise.This i...

ACN Newswire
Read More

Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials

indie
3 minutes

SYDNEY, AU, Dec 6, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the Year Award 2022 for Best Practices in the Asia-Pacific contract research organization industry. Novotech has been a recipient of the Frost & Sullivan Asia Pacific Best Practices awards since 2006.Frost & Sullivan identifies companies that consistently develop growth strategies based on a visionary understanding of the future, and effectively address new challenges and opportunities.Frost & Sullivan said: "Our approach involves the deployment of best practices and strategic analytics across a value chain. Against this backdrop, Frost & Sullivan recognizes Novotech for its valuable achievement. Novotech addresses the global drug development market's unmet needs with a strong leadership focus that incorporates client-centric strategies with best-practice implementation. From feasibility assessments to regulatory submission support, data management, medical monitoring, and project management, the company provides a 360-degree approach to drug development for its biotech clients."In response to th...

ACN Newswire
Read More

IBO Technology Announces 2022 Interim Results

indie
8 minutes

HONG KONG, Nov 30, 2022 - (ACN Newswire via SEAPRWire.com) - IBO Technology Company Limited ("IBO Technology", or the "Company", together with its subsidiaries, the "Group"; Stock Code: 2708.HK) is pleased to announce its unaudited interim results for the six months ended 30 September 2022 (the "Period"). To promote the business development of Information Technology Application Innovation Information ("ITAI") and seize the industry golden opportunities, the Group cooperated with the People's Government of Fucheng District, Mianyang City, Sichuan Province ("Fucheng District People's Government") during the Period to develop an intelligent manufacturing industrial park project.During the Period, the demand for ITAI IT (terminal products and industry solutions), 5G (communication equipment and private network solutions) and Internet of Things ("IoT") (products and industry solutions), the Group's three major business segments, increased steadily and showed a positive development trend. The Group's revenue for the Period increased by approximately 37.5% to approximately RMB366.15 million (six months ended 30 September 2021: approximately RMB266.28 million), which was mainly benefited f...

JCN Newswire
Read More

Consortium of Japan partners successfully promote domestic production and cost reduction for 5G core technology, the basis for next-generation communication standards

ruth
7 minutes

TOKYO, Nov 24, 2022 - (JCN Newswire via SEAPRWire.com) - The University of Tokyo, Internet Initiative Japan (IIJ), APRESIA, and Fujitsu Limited have successfully developed Open Source Software for the Private 5G/6G Mobile System, realizing a domestically produced, low-cost 5G core network (5GC), the core technology of the 5G mobile network. The initiative was conducted by the partners as part of NEDO's Research and Development Project of the Enhanced Infrastructures for Post-5G Information and Communication Systems Feasibility Study (Contracted).Figure 1: Image of the Newly Developed 5GCFigure 2: Image of Private 5G System Commercialized by APRESIA and FujitsuFigure 3: Image of Multiple Private 5G Systems Promoted by IIJ5GC software plays a central role in controlling cell phone networks, but the need for domestic production and cost reduction represents ongoing challenges to making related technologies, like private 5G, a reality. With the development of this new technology, IIJ, APRESIA, and Fujitsu developed a practical version of 5GC based on Open Source Software with commercial-level functionality, performance, and stability based on Open Source Software. The University of Tok...

ACN Newswire
Read More

Pertamina, ExxonMobil agree to develop CCS for decarbonization

indie
3 minutes

JAKARTA, Nov 15, 2022 - (ACN Newswire via SEAPRWire.com) - Pertamina and ExxonMobil have signed a cooperation agreement for developing carbon capture and storage (CCS) for cutting carbon emissions while supporting economic growth.Pertamina and ExxonMobil have signed a cooperation agreement for developing carbon capture and storage (CCS) as part of efforts to reduce carbon emissions while supporting economic growth. (ANTARA/Pertamina)"This collective agreement is a solid foundation for Indonesia to achieve Indonesia's net-zero target by 2060 or sooner," Coordinating Minister for Maritime Affairs and Investment Luhut Binsar Pandjaitan said on Monday.The Indonesian government is working on developing regulations that support carbon capture and storage (CCS) and starting discussions with governments in other regions, he added.Meanwhile, Pertamina's CEO and president director, Nicke Widyawati, said that the CCS development and decarbonization cooperation is in line with Pertamina's efforts to support the government's program to accelerate the energy transition and achieve the target of reducing emissions by 29 percent by 2030."The development of CCS technology is in line with Pertamina'...

ACN Newswire
Read More

Grand Ming Group Holdings Limited Announces Interim Results for the Six Months Ended 30 September 2022

indie
7 minutes

HONG KONG, Nov 12, 2022 - (ACN Newswire via SEAPRWire.com) - Grand Ming Group Holdings Limited (the "Company" and together with its subsidiaries, the "Group", stock code: 1271.HK) today announces its interim results for the six months ended 30 September 2022 ("FH 2022/23").Highlights-- Revenue amounted to HK$4.92 billion, an increase of 7.4 times from the last corresponding period.-- Profit for the period was HK$1.41 billion, representing a year-on-year increase of 19.4 times.-- Declared payment of an interim dividend of 6.0 HK cents per share.-- Stay positive toward lucrative business of owning and operating data centres via expanding portfolio of developing two new centres in near future.-- Seize opportunity to increase land reserve for property development in Hong Kong.-- Continue to execute the plan for property development in Nanning, Guangxi Province, China.The Group's consolidated revenue increased by 7.4 times from HK$586.1 million for the six months ended 30 September 2021 ("FH 2021/22") to HK$4,920.1 million for FH 2022/23. The Group recorded a net profit for FH 2022/23 was HK$1,410.2 million, representing an increase of 19.4 times when compared to that of HK$69.2 million...

ACN Newswire
Read More

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

indie
4 minutes

SYDNEY, AU, Nov 11, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, and Novotech's Chief Commercial Officer Barry Murphy is Session Chair for the expert panel on How to Build and Finance an East-West MRCT Strategy Workshop at the Summit (14-16 November 2022).Novotech is sponsoring the Networking Reception and Dinner.Workshop details:Global Development Workshop: How to Build and Finance an East-West MRCT StrategyNovember 15, 20222:30 PM - (PACIFIC TIME ZONE) BioCentury-BayHelix East-West Summit 2022https://conferences.biocentury.com/china-healthcare-summit/schedulePanelists are:- PATRICIA KEEGAN, M.D.: Chief Medical Officer, Junshi Biosciences- KE LIU, M.D., PH.D.: Chief Development Officer, Marengo Therapeutics- ROGER LUO, PH.D.: Chief Development Officer, Overland Pharmaceuticals- PEONY YU, M.D.: Chief Medical Officer, Apollomics Inc.Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.Commenting on Novotech's experience, Chief Commercial Officer B...

ACN Newswire
Read More

SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company

indie
4 minutes

HONG KONG, Nov 4, 2022 - (ACN Newswire via SEAPRWire.com) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that, Mr. Shanchun WANG has been appointed as the President (China) of the Company. Mr. Wang will mainly be responsible for the China operation.Mr. Shanchun WANG, served as the executive director of Sino Biopharmaceutical Limited (stock code: 1177) and the president of Chia Tai - Tianqing Pharmaceutical Group Co. Ltd., joined SinoMab lately as the President (China) of the Company. Mr. Shanchun WANG has rich experience and practical achievements in corporate strategic management, organizational management, innovation research and development and product commercialization. He is a specialist that granted the special government allowances of the State Council and awarded as a national model worker, a Jiangsu Province Technology Advanced Worker, a Jiangsu Province Model Labour, a winner of the Shanghai Tec...

ACN Newswire
Read More

“New Life in the GBA” Lucky Draw by Greater Bay Area Homeland Youth Community Foundation Concluded with 521 Happy Winners

indie
4 minutes

HONG KONG, Oct 27, 2022 - (ACN Newswire via SEAPRWire.com) - With its tremendous development, the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) offers endless opportunities to Hong Kong Youth. The "New Life in the GBA" lucky draw launched by the Greater Bay Area Homeland Youth Community Foundation (the Foundation) ran from April to September this year aimed to support the development of young people in Hong Kong in establishing new lives in the GBA. The lucky draw received positive responses from young Hong Kong residents aged between 18 to 45. All eligible participants held a valid Mainland Travel Permit for Hong Kong and Macao Residents, had successfully registered as a YO PLACE member and held a "GBA Youth Card". 521 prizes were drawn live at YO PLACE yesterday on 25 October.We were pleased to have Mr Tommy Yuen Man-chung, Commissioner for the Development of the Guangdong-Hong Kong-Macao Greater Bay Area, Mr Bunny Chan Chung-bun, Hong Kong Delegate to the National People's Congress, and Mr Daryl Ng Win-kong, Chairman of Greater Bay Area Homeland Youth Community Foundation as the officiating guests, as well as Mr Nicholas Chan Hiu-fung, Honorary Legal adviser of the Foundation...

ACN Newswire
Read More

ONERHT partners Democratic Republic of Congo for sustainable economic development and growth

indie
4 minutes

SINGAPORE, Oct 25, 2022 - (ACN Newswire via SEAPRWire.com) - Sustainability consultancy RHT Green and strategic advisory firm RHT Consulting Asia have entered into a Memorandum of Understanding (MOU) with the Ministry of Environment and Sustainable Development of the Democratic Republic of Congo (DRC) to support the implementation of multisectoral sustainable development projects in the central African country.H.E. Deputy Prime Minister for the Environment and Sustainable Development, Democratic Republic of Congo (centre), during her visit to ONERHT's office in SingaporeRHTLaw Asia and RHT Group of Companies, which includes RHT Green and RHT Consulting Asia (collectively "ONERHT"), welcomed the delegation of Her Excellency Eve Bazaiba, Deputy Prime Minister for the Environment and Sustainable Development of the DRC on her maiden visit to Asia.Hosted by ONERHT, Her Excellency was briefed on Singapore's approach to sustainable development and exchanged ideas for sustainable development and green growth in the DRC. The MOU marks the culmination of discussions between the parties on sustainable value creation strategies and efforts to design effective environmental policies for the DRC...

ACN Newswire
Read More

Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper

indie
3 minutes

SYDNEY, AU, Oct 25, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert guidance on pathways to USFDA approval for biotechs conducting research in China.Download whitepaper here https://novotech-cro.com/whitepapers/china-biotech-landscape-opportunities-china-and-path-usfda-approval The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.Novotech's Vice President, Global Head of Clinical Services Dr. Yooni Kim said: "China presents exceptional clinical opportunities with vast populations and word-class research facilities and KOLs. This concise analysis of the pathway to USFDA approval expertly informs clinical stage biotechs about the China research benefits and how to manage any challenges. The report details the regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful USFDA approval pathway. Novotech, with experienced clinical teams ...

ACN Newswire
Read More

The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval

indie
3 minutes

SYDNEY, AU, Oct 17, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar for biotechs considering the clinical research opportunities in Asia Pacific and the regulatory pathways to achieving FDA approval.Novotech has operations across Asia Pacific and the US offering a unique and unparalleled suite of CRO services for early to late phase biotech clinical research.The webinar features regulatory affairs and investment leaders from North America and Asia Pacific who will discuss:- why biotech companies are increasingly exploring clinical opportunities in Asia Pacific to generate diverse, globally accepted clinical trial data- what actionable strategies can be implemented to leverage Asia Pacific's recruitment potential to accelerate your clinical development- how Phase 1 data from Australia is acceptable to the FDA and can be used to launch global drug development programs- deep insight into processes for designing and delivering a robust clinical program- biotech challenges and opportunities in the post-COVID environment with a focus on global investments and drug pipelinesRegister for the webinar h...

JCN Newswire
Read More

MHI Signs Statement of Cooperation with the State Government of South Australia on Development of Local Hydrogen Industry

ruth
2 minutes

TOKYO, Oct 13, 2022 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) signed a Statement of Cooperation on October 10 with the State Government of South Australia aimed at accelerating development of the local hydrogen industry. By proposing diverse solutions incorporating its Groupwide products, technologies and services, MHI looks to collaborate with South Australia in the state's transition to clean energy and development of a hydrogen economy.The Statement of Cooperation was signed by The Hon Peter Malinauskas MP, Premier of South Australia, and MHI Senior Vice President Osamu Ono, who concurrently serves as Chief Regional Officer of both the Asia Pacific and India as well as President of Mitsubishi Heavy Industries Asia Pacific Pte. Ltd. Specifically, MHI will propose solutions in the following areas: growing a globally competitive hydrogen export sector through the development of a hydrogen export strategy and strategic partnerships; fostering advances in new technologies and new industrial opportunities through research partnerships; projects that accelerate the development of large-scale industrial decarbonization programs; and developing near-ter...